APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceritinib

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ceritinib Market Outlook and Growth Opportunities 2026

23 December 2025192 pages

Choose your research edition.

Industry ResearchCeritinib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceritinib Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Ceritinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceritinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceritinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ceritinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ceritinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ceritinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceritinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ceritinib market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ceritinib market include Lucius Pharmaceuticals, Natco and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ceritinib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ceritinib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ceritinib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ceritinib market size, projected growth trends, production technologies, key applications, and end-use industries.

Ceritinib Segment by Company

Lucius Pharmaceuticals

Natco

Novartis

Ceritinib Segment by Type

90 Capsules/Box

50 Capsules/Box

150 Capsules/Box

Ceritinib Segment by Application

Clinic

Hospital

Pharmacy

Others

Ceritinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ceritinib status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ceritinib market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ceritinib significant trends, drivers, influence factors in global and regions.

6. To analyze Ceritinib competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceritinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceritinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceritinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ceritinib market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ceritinib industry.

Chapter 3: Detailed analysis of Ceritinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ceritinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ceritinib in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ceritinib Industry Trends Table 2. Ceritinib Industry Drivers Table 3. Ceritinib Industry Opportunities and Challenges Table 4. Ceritinib Industry Restraints Table 5. Global Ceritinib Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ceritinib Revenue Share by Company (2021-2026) Table 7. Global Ceritinib Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Ceritinib Sales Volume Share by Company (2021-2026) Table 9. Global Ceritinib Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Ceritinib Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ceritinib Key Company Manufacturing Base & Headquarters Table 12. Global Ceritinib Company, Product Type & Application Table 13. Global Ceritinib Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ceritinib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 90 Capsules/Box Table 18. Significant Companies of 50 Capsules/Box Table 19. Significant Companies of 150 Capsules/Box Table 20. Global Ceritinib Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 21. Global Ceritinib Sales Volume by Type (2021-2026) & (k pcs) Table 22. Global Ceritinib Sales Volume by Type (2027-2032) & (k pcs) Table 23. Global Ceritinib Sales Volume Share by Type (2021-2026) Table 24. Global Ceritinib Sales Volume Share by Type (2027-2032) Table 25. Global Ceritinib Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ceritinib Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Ceritinib Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Ceritinib Sales Value Share by Type (2021-2026) Table 29. Global Ceritinib Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinic Table 31. Significant Companies of Hospital Table 32. Significant Companies of Pharmacy Table 33. Significant Companies of Others Table 34. Global Ceritinib Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 35. Global Ceritinib Sales Volume by Application (2021-2026) & (k pcs) Table 36. Global Ceritinib Sales Volume by Application (2027-2032) & (k pcs) Table 37. Global Ceritinib Sales Volume Share by Application (2021-2026) Table 38. Global Ceritinib Sales Volume Share by Application (2027-2032) Table 39. Global Ceritinib Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Ceritinib Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Ceritinib Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Ceritinib Sales Value Share by Application (2021-2026) Table 43. Global Ceritinib Sales Value Share by Application (2027-2032) Table 44. Global Ceritinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 45. Global Ceritinib Sales by Region (2021-2026) & (k pcs) Table 46. Global Ceritinib Sales Market Share by Region (2021-2026) Table 47. Global Ceritinib Sales by Region (2027-2032) & (k pcs) Table 48. Global Ceritinib Sales Market Share by Region (2027-2032) Table 49. Global Ceritinib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Ceritinib Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Ceritinib Sales Value Share by Region (2021-2026) Table 52. Global Ceritinib Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Ceritinib Sales Value Share by Region (2027-2032) Table 54. Global Ceritinib Market Average Price (US$/pcs) by Region (2021-2026) Table 55. Global Ceritinib Market Average Price (US$/pcs) by Region (2027-2032) Table 56. Global Ceritinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 57. Global Ceritinib Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Ceritinib Sales by Country (2021-2026) & (k pcs) Table 59. Global Ceritinib Sales Market Share by Country (2021-2026) Table 60. Global Ceritinib Sales by Country (2027-2032) & (k pcs) Table 61. Global Ceritinib Sales Market Share by Country (2027-2032) Table 62. Global Ceritinib Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Ceritinib Sales Value Market Share by Country (2021-2026) Table 64. Global Ceritinib Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Ceritinib Sales Value Market Share by Country (2027-2032) Table 66. Lucius Pharmaceuticals Company Information Table 67. Lucius Pharmaceuticals Business Overview Table 68. Lucius Pharmaceuticals Ceritinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 69. Lucius Pharmaceuticals Ceritinib Product Portfolio Table 70. Lucius Pharmaceuticals Recent Development Table 71. Natco Company Information Table 72. Natco Business Overview Table 73. Natco Ceritinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Natco Ceritinib Product Portfolio Table 75. Natco Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Ceritinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Novartis Ceritinib Product Portfolio Table 80. Novartis Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Ceritinib Distributors List Table 84. Ceritinib Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Ceritinib Product Image Figure 2. Global Ceritinib Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceritinib Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ceritinib Sales (2021-2032) & (k pcs) Figure 5. Global Ceritinib Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Ceritinib Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 90 Capsules/Box Image Figure 10. 50 Capsules/Box Image Figure 11. 150 Capsules/Box Image Figure 12. Global Ceritinib Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 13. Global Ceritinib Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Ceritinib Sales Volume Share by Type (2021-2032) Figure 15. Global Ceritinib Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ceritinib Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ceritinib Sales Value Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Hospital Image Figure 20. Pharmacy Image Figure 21. Others Image Figure 22. Global Ceritinib Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 23. Global Ceritinib Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Ceritinib Sales Volume Share by Application (2021-2032) Figure 25. Global Ceritinib Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Ceritinib Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Ceritinib Sales Value Share by Application (2021-2032) Figure 28. Global Ceritinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 29. Global Ceritinib Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Ceritinib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Ceritinib Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Ceritinib Sales Value (2021-2032) & (US$ Million) Figure 33. North America Ceritinib Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Ceritinib Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Ceritinib Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Ceritinib Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Ceritinib Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Ceritinib Sales Value (2021-2032) & (US$ Million) Figure 39. South America Ceritinib Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Ceritinib Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Ceritinib Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Ceritinib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Ceritinib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Ceritinib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Ceritinib Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Ceritinib Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 90 Capsules/Box
  • 50 Capsules/Box
  • 150 Capsules/Box
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Lucius Pharmaceuticals
  • Natco
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceritinib Sales Value (2021-2032)
  4. 1.2.2 Global Ceritinib Sales Volume (2021-2032)
  5. 1.2.3 Global Ceritinib Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ceritinib Market Dynamics
  1. 2.1 Ceritinib Industry Trends
  2. 2.2 Ceritinib Industry Drivers
  3. 2.3 Ceritinib Industry Opportunities and Challenges
  4. 2.4 Ceritinib Industry Restraints
3 Ceritinib Market by Company
  1. 3.1 Global Ceritinib Company Revenue Ranking in 2025
  2. 3.2 Global Ceritinib Revenue by Company (2021-2026)
  3. 3.3 Global Ceritinib Sales Volume by Company (2021-2026)
  4. 3.4 Global Ceritinib Average Price by Company (2021-2026)
  5. 3.5 Global Ceritinib Company Ranking (2024-2026)
  6. 3.6 Global Ceritinib Company Manufacturing Base and Headquarters
  7. 3.7 Global Ceritinib Company Product Type and Application
  8. 3.8 Global Ceritinib Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ceritinib Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ceritinib Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ceritinib Market by Type
  1. 4.1 Ceritinib Type Introduction
  2. 4.1.1 90 Capsules/Box
  3. 4.1.2 50 Capsules/Box
  4. 4.1.3 150 Capsules/Box
  5. 4.2 Global Ceritinib Sales Volume by Type
  6. 4.2.1 Global Ceritinib Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ceritinib Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Ceritinib Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Ceritinib Sales Value by Type
  10. 4.3.1 Global Ceritinib Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ceritinib Sales Value by Type (2021-2032)
  12. 4.3.3 Global Ceritinib Sales Value Share by Type (2021-2032)
5 Ceritinib Market by Application
  1. 5.1 Ceritinib Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Ceritinib Sales Volume by Application
  7. 5.2.1 Global Ceritinib Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ceritinib Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ceritinib Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ceritinib Sales Value by Application
  11. 5.3.1 Global Ceritinib Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ceritinib Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ceritinib Sales Value Share by Application (2021-2032)
6 Ceritinib Regional Sales and Value Analysis
  1. 6.1 Global Ceritinib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ceritinib Sales by Region (2021-2032)
  3. 6.2.1 Global Ceritinib Sales by Region: 2021-2026
  4. 6.2.2 Global Ceritinib Sales by Region (2027-2032)
  5. 6.3 Global Ceritinib Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ceritinib Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ceritinib Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ceritinib Sales Value by Region (2027-2032)
  9. 6.5 Global Ceritinib Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ceritinib Sales Value (2021-2032)
  12. 6.6.2 North America Ceritinib Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ceritinib Sales Value (2021-2032)
  15. 6.7.2 Europe Ceritinib Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ceritinib Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ceritinib Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ceritinib Sales Value (2021-2032)
  21. 6.9.2 South America Ceritinib Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ceritinib Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ceritinib Sales Value Share by Country, 2025 VS 2032
7 Ceritinib Country-level Sales and Value Analysis
  1. 7.1 Global Ceritinib Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ceritinib Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ceritinib Sales by Country (2021-2032)
  4. 7.3.1 Global Ceritinib Sales by Country (2021-2026)
  5. 7.3.2 Global Ceritinib Sales by Country (2027-2032)
  6. 7.4 Global Ceritinib Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ceritinib Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ceritinib Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ceritinib Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ceritinib Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ceritinib Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ceritinib Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ceritinib Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ceritinib Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ceritinib Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ceritinib Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ceritinib Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ceritinib Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ceritinib Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ceritinib Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ceritinib Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ceritinib Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ceritinib Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ceritinib Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ceritinib Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ceritinib Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ceritinib Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ceritinib Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ceritinib Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ceritinib Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ceritinib Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ceritinib Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ceritinib Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ceritinib Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ceritinib Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ceritinib Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ceritinib Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ceritinib Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ceritinib Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ceritinib Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ceritinib Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ceritinib Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ceritinib Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ceritinib Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ceritinib Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ceritinib Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ceritinib Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ceritinib Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ceritinib Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ceritinib Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ceritinib Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ceritinib Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ceritinib Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ceritinib Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ceritinib Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ceritinib Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ceritinib Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ceritinib Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ceritinib Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ceritinib Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ceritinib Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ceritinib Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ceritinib Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ceritinib Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ceritinib Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ceritinib Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ceritinib Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ceritinib Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ceritinib Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ceritinib Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ceritinib Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ceritinib Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ceritinib Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ceritinib Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ceritinib Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ceritinib Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ceritinib Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ceritinib Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ceritinib Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ceritinib Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ceritinib Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ceritinib Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ceritinib Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ceritinib Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ceritinib Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ceritinib Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ceritinib Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ceritinib Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ceritinib Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ceritinib Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ceritinib Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ceritinib Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lucius Pharmaceuticals
  2. 8.1.1 Lucius Pharmaceuticals Company Information
  3. 8.1.2 Lucius Pharmaceuticals Business Overview
  4. 8.1.3 Lucius Pharmaceuticals Ceritinib Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lucius Pharmaceuticals Ceritinib Product Portfolio
  6. 8.1.5 Lucius Pharmaceuticals Recent Developments
  7. 8.2 Natco
  8. 8.2.1 Natco Company Information
  9. 8.2.2 Natco Business Overview
  10. 8.2.3 Natco Ceritinib Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Natco Ceritinib Product Portfolio
  12. 8.2.5 Natco Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Ceritinib Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Ceritinib Product Portfolio
  18. 8.3.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ceritinib Value Chain Analysis
  2. 9.1.1 Ceritinib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ceritinib Sales Mode & Process
  6. 9.2 Ceritinib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ceritinib Distributors
  9. 9.2.3 Ceritinib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst